Literature DB >> 8321151

Variation in field isolates of measles virus during an 8-year period in Japan.

H Sakata1, F Kobune, T A Sato, K Tanabayashi, A Yamada, A Sugiura.   

Abstract

Field isolates of measles virus (MV) during an 8-year period in four areas of Japan, i.e., Osaka, Nagoya, Tokyo and Akita, were classified into three types in regard to the electrophoretic mobility of the hemagglutinin (HA) proteins: S type with small (78K) HA, M type with intermediate (80 K) HA and L type with large (82 K) HA. The type of field isolates was closely related with the geographical location and the year of virus isolation. The S type strain was isolated only in an outbreak from 1983 to 1984, whereas the M and L type strains were isolated between 1983 and 1990. The HA genes of the M and L type strains of MV were found to have a nucleotide substitution which introduces a new potential glycosylation site. In addition, the matrix proteins of all field strains isolated after 1977 showed slower electrophoretic mobility of 42 K than 39 K of the Edmonston and Toyoshima strains. These results indicate that MV strains of different HA types existed concomitantly and that major populations of MV currently circulating in Japan are changing from those prevalent in 1983-1984.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8321151     DOI: 10.1111/j.1348-0421.1993.tb03205.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  9 in total

1.  Recombinant wild-type and edmonston strain measles viruses bearing heterologous H proteins: role of H protein in cell fusion and host cell specificity.

Authors:  Kaoru Takeuchi; Makoto Takeda; Naoko Miyajima; Fumio Kobune; Kiyoshi Tanabayashi; Masato Tashiro
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Nucleotide sequences of the M gene of prevailing wild measles viruses and a comparison with subacute sclerosing panencephalitis virus.

Authors:  C Kai; K Yamanouchi; H Sakata; N Miyashita; H Takahashi; F Kobune
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

3.  Molecular epidemiology and changing distribution of genotypes of measles virus field strains in Japan.

Authors:  Y Katayama; K Shibahara; T Kohama; M Homma; H Hotta
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

4.  Comparative analysis of titers of antibody against measles virus in sera of vaccinated and naturally infected Japanese individuals of different age groups.

Authors:  Masae Itoh; Yoshinobu Okuno; Hak Hotta
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

5.  Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently.

Authors:  Maino Tahara; Makoto Takeda; Fumio Seki; Takao Hashiguchi; Yusuke Yanagi
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

6.  Activity of polymerase proteins of vaccine and wild-type measles virus strains in a minigenome replication assay.

Authors:  Bettina Bankamp; Sean P Kearney; Xin Liu; William J Bellini; Paul A Rota
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  Functional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein.

Authors:  Maino Tahara; Yuri Ito; Melinda A Brindley; Xuemin Ma; Jilan He; Songtao Xu; Hideo Fukuhara; Kouji Sakai; Katsuhiro Komase; Paul A Rota; Richard K Plemper; Katsumi Maenaka; Makoto Takeda
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

Review 8.  Genetic diversity of wild-type measles viruses: implications for global measles elimination programs.

Authors:  W J Bellini; P A Rota
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

Review 9.  Measles Virus Hemagglutinin Protein Epitopes: The Basis of Antigenic Stability.

Authors:  Maino Tahara; Jean-Philippe Bürckert; Kazuhiko Kanou; Katsumi Maenaka; Claude P Muller; Makoto Takeda
Journal:  Viruses       Date:  2016-08-02       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.